Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | May 15, 2024 | 13.66 | -2.01 |
Oak Valley Bancorp | OVLY | May 15, 2024 | 24.30 | -1.82 |
Oak Woods Acquisition | OAKU | May 15, 2024 | 10.78 | 0.00 |
Oaktree Capital A Pref | OAK-A | May 15, 2024 | 22.33 | +0.00 |
Oaktree Capital Group B Pref | OAK-B | May 15, 2024 | 22.01 | -0.09 |
Oaktree Specialty | OCSL | May 15, 2024 | 19.24 | -1.18 |
Oatly ADR | OTLY | May 15, 2024 | 1.24 | 0.00 |
Oblong | OBLG | May 15, 2024 | 0.15 | +24.23 |
OCA Acquisition A | OCAX | May 15, 2024 | 11.18 | +1.96 |
Occidental Petroleum | OXY | May 15, 2024 | 63.38 | +0.51 |
Ocean Biomedical | OCEA | May 15, 2024 | 1.74 | +11.54 |
Ocean Power Technologies | OPTT | May 15, 2024 | 0.19 | -4.55 |
Oceaneering International | OII | May 15, 2024 | 23.49 | 0.00 |
OceanFirst Financial | OCFC | May 15, 2024 | 16.06 | +1.77 |
OceanFirst Pref | OCFCP | May 15, 2024 | 24.50 | -0.57 |
OceanPal | OP | May 15, 2024 | 2.51 | -3.09 |
Ocugen | OCGN | May 15, 2024 | 1.96 | +15.29 |
Ocular Therapeutix | OCUL | May 15, 2024 | 6.29 | +3.97 |
Oculis | OCS | May 15, 2024 | 12.01 | -1.23 |
Ocuphire Pharma | OCUP | May 15, 2024 | 1.73 | +1.76 |
Ocwen Financial | OCN | May 15, 2024 | 25.66 | +1.50 |
Oddity Tech | ODD | May 15, 2024 | 43.68 | +0.88 |
Odyssey Marine Exploration | OMEX | May 15, 2024 | 3.79 | -10.82 |
Offerpad Solutions A | OPAD | May 15, 2024 | 6.40 | -12.57 |
Office Properties | OPI | May 15, 2024 | 2.34 | -9.50 |
OFG Bancorp | OFG | May 15, 2024 | 38.14 | +1.22 |
OFS Capital | OFS | May 15, 2024 | 9.63 | +0.84 |
OFS Credit | OCCI | May 15, 2024 | 7.61 | +3.00 |
OFS Credit C Pref | OCCIO | May 15, 2024 | 24.12 | +0.06 |
OFS Credit E Pref | OCCIN | May 15, 2024 | 23.28 | -0.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.